media-29-clinicalomics-natalis

CLINICALOMICS | 02.09.18

Sema4 Supplemental Test for Newborns Screens for 193 Diseases

“Genomic testing and health information company Sema4 has launched a newborn test that screens for 193 childhood-onset diseases and disorders with the intention of providing parents with additional information about the health of their newborn baby. Sema4 Natalis serves as an additional testing method for conditions beyond the 34 conditions on the Recommended Uniform Screening Panel (RUSP), typically screened in U.S.-based hospitals shortly after birth…”